The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

He said this “would turn said target into a vegetable for the rest of its life”. In response to the creator of the AstraZeneca vaccine getting a standing ovation at Wimbledon, he commented: “It’s a ...

The term digital twin is more than a decade old, but it is only in recent years with the acceleration of AI that the term has gathered pace. A digital twin is a virtual replica of a physical process – ...

GUEST OPINION: The term digital twin is more than a decade old, but it is only in recent years with the acceleration of AI that the term has gathered pace. A digital twin is a virtual replica of a ...

AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS ...

ENRICHED CTCS AND CTDNA PROVIDES COMPLEMENTARY INFORMATION IN NSCLC PATIENTS TREATED WITH ASTRAZENECA'S OSIMERTINIBThe addition of CTC-DNA analysis to clinical trials could identify patients ...

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a digital health company transforming care through the power of portable, ...